Skip to main content
Have a personal or library account? Click to login
Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes Cover

Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes

Acta Pharmaceutica
Volume 65 (2015): Issue 2 (June 2015)
By: ,  ,  ,  ,   and    
Open Access
|May 2015
References

References

  1. 1. D. M. Campoli-Richards, E. M. Sorkin and R. C. Heel, Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, Drugs 32 (1986) 383-424.
    Open DOISearch in Google Scholar
  2. 2. H. Ohnishi, H. Kosuzume, H. Inaba, M. Ohkura, S. Shimada and Y. Suzuki, The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections, Int. J. Immunopharmacol. 5 (1983) 181-196.
    Open DOISearch in Google Scholar
  3. 3. H. Ohnishi, H. Kosuzume, H. Inaba, M. Okura, Y. Morita, H. Mochizuki and Y. Suzuki, Mechanism of host defence suppression induced by viral infection: mode of action of inosiplex as an antiviral agent, Infect. Immun. 38 (1982) 243-250.
    Search in Google Scholar
  4. 4. K. Y. Tsang, H. H. Fudenberg and M. J. Gnagy, Restoration of immune response of aging hamsters by treatment with isoprinosine, J. Clin. Invest. 71 (1983) 1750-1755; DOI: 10.1A2/JCI110930.
    Open DOISearch in Google Scholar
  5. 5. J. Gutierrez, R. S. Issacson and B. S. Koppel, Subacute sclerosing panencephalitis: an update, Dev. Med. Child. Neurol. 52 (2010) 901-907; DOI: 10.1111/j.1469-8749.2010.03717.x.
    Open DOISearch in Google Scholar
  6. 6. C. Pedersen, E. Sandstrocm, C. S. Petersen, G. Norkrans, J. Gerstoft , A. Karlsson, K. C. Christensen, C. Hakanson, P. Pehrson, J. O. Nielsen, H. J. Jucrgensen, and Scandinavian Isoprinosine Study Group, The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection, New Engl. J. Med. 322 (1990) 1757-1763; DOI: 10.1056/NEJM199006213222501.
    Open DOISearch in Google Scholar
  7. 7. T. Nakamura, N. Miyasaka, R. M. Pope, N. Talal and I. J. Russell, Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases, Clin. Exp. Immunol. 52 (1983) 67-74.
    Search in Google Scholar
  8. 8. J. W. Hadden, E. M. Hadden and R. G. Coffey, Isoprinosine augmentation of phytohemagglutinininduced lymphocyte proliferation, Infect. Immun. 13 (1976) 382-387.
    Open DOISearch in Google Scholar
  9. 9. J. Litzman, J. Lokaj, M. Krejci, S. Pesak and G. Morgan, Isoprinosine does not protect against frequent respiratory tract infections in childhood, Eur. J. Pediatr. 158 (1999) 32-37.
    Open DOISearch in Google Scholar
  10. 10. M. Gołębiowska-Wawrzyniak, K. Markiewicz, A. Kozar, P. Derentowicz, J. Czerwińska-Kartowicz, K. Jastrzębska-Janas, J. Wacławek, Z. M. Wawrzyniak and H. Siwinska-Gołębiowska, Immunological and clinical study on the therapeutic efficacy of inosine pranobex, Pol. Merkur. Lekarski 19 (2005) 379-382.
    Search in Google Scholar
  11. 11. P. Hersey and A. Edwards, Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo, Int. J. Immunopharmacol. 6 (1984) 315-320; DOI: 10.1016/0192-0561(84)90048-1.
    Open DOISearch in Google Scholar
  12. 12. S. Milano, M. Dieli, S. Millott , M. D. Miceli, E. Maltese and E. Cillari, Effect of isoprinosine on IL-2, IFN-γ and IL-4 production in vivo and in vitro, Int. J. Immunopharmacol. 13 (1991) 1013-1018; DOI: 10.1016/0192-0561(91)90055-C.
    Open DOISearch in Google Scholar
  13. 13. S. Jiang and C. Dong, A complex issue on CD4+ T-cell subsets, Immunol. Rev. 252 (2013) 5-11; DOI: 10.1111/imr.12041.
    Open DOISearch in Google Scholar
  14. 14. S. McHugh, J. Deighton, I. Rifkin and P. Ewan, Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture, Eur. J. Immunol. 26 (1996) 1260-1265; DOI: 10.1002/eji.1830260612.
    Open DOISearch in Google Scholar
  15. 15. B. Perussia, The cytokine profile of resting and activated NK cells, Methods 9 (1996) 370-378; DOI: 10.1084/jcm.20032058.
    Search in Google Scholar
  16. 16. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, C. Kegel, R. Disch, C. B. Schmidt-Weber, K. Blaser and C. A. Akdis, Immune response in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J. Exp. Med. 199 (2004) 1567-1575.
    Open DOISearch in Google Scholar
  17. 17. I. Striz, E. Brabcova, L. Kolesar and A. Sekerkova, Cytokine networking of innate immunity cells: a potential target of therapy, Clin. Sci. 126 (2014) 593-612; DOI: 10.1042/CS20130497.
    Open DOISearch in Google Scholar
  18. 18. B. K. Pedersen, N. Tvede, M. Diamant, J. Gerstoft , M. Bagge Hansen, P. M. Haahr, M. Hording, M. Kappel, M. Klokker, B. Soeberg and P. Skinhoj, Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumor necrosis factor, and interleukins 1, 2, and 6, Scand. J. Immunol. 32 (1990) 641-649.
    Open DOISearch in Google Scholar
  19. 19. M. Petrova, D. Jelev and Z. Krastev, Isoprinosine affects serum cytokine levels in healthy adults, J. Interferon Cytokine Res. 30 (2010) 223-227; DOI: 10.1089/jir.2009.0057.
    Open DOISearch in Google Scholar
  20. 20. R. Sabat, G. Grutz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk and J. Geginat, Biology of interleukin-10, Cytokine Growth Factor Rev. 21 (2010) 331-344; DOI: 1016/j.cytogfr.2010.09.002.
    Open DOISearch in Google Scholar
  21. 21. A. Langkjaer, B. Kristensen, B. E. Hansen, H. Schultz, L. Hegedus and C. H. Nielsen, B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6- and TNF-α-producing B-cell subsets in healthy humans, Clin. Immunol. 145 (2012) 1-10; DOI: 10.1016/j.clim.2012.07.004.
    Open DOISearch in Google Scholar
  22. 22. M. Saraiva and A. O’Garra, The regulation of IL-10 production by immune cells, Nat. Rev. Immunol. 10 (2010) 170-181; DOI: 10.103/nri2711.
    Open DOISearch in Google Scholar
  23. 23. G. Del Prete, M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagotti and S. Romagnani, Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation an cytokine production, J. Immunol. 150 (1993) 353-360.
    Open DOISearch in Google Scholar
  24. 24. S. Gregori, K. S. Goudy and M. G. Roncarolo, The cellular and molecular mechanisms of immunosuppression by human type 1 regulatory T cells, Front. Immunol. 3 (2012), article 30; DOI: 10.3389/ fimmu.2012.00030.
    Search in Google Scholar
  25. 25. A. A. Navarini, M. Recher, K. S. Lang, P. Georgiev, S. Meury, A. Bergthaler, L. Flatz, J. Bille, R. Landmann, B. Odermatt , H. Hengartner and R. M. Zinkernagel, Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses, PNAS 103 (2006) 15335-15539; DOI: 10.1073/pnas.0607225103.
    Search in Google Scholar
  26. 26. W. W. Metzger and K. Sun, Immune dysfunction and bacterial coinfections following influenza, J. Immunol. 191 (2013) 2047-2052; DOI: 10.4049/jimmunol.1301152.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/acph-2015-0015 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 171 - 180
Accepted on: Nov 20, 2014
Published on: May 23, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
inosine pranobex,
immunomodulation,
cytokines,
IL-10
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 Witold Lasek, Michał Janyst, Rafał Wolny, Łukasz Zapała, Katarzyna Bocian, Nadzieja Drela, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 65 (2015): Issue 2 (June 2015)
Previous article
Next article